(Date:5/17/2008)...ed Spokesperson for Education Campaign on Behalf o...teinase Inhibitor (Human) Augmentation ..., May 17 /PRNewswire/ -- Melissa Biggs, a fashion,...recently named,spokesperson for an education campa...ans to get tested for alpha-1 antitrypsin (AAT) de...
(Date:5/16/2008)NEW YORK, May 16 /PRNewswire/ -- There,s more to a healthy mouth than,flashing a set of pearly whites. Here,s the scoop on America,s oral care,habits - and what it means for our overall health.,
(Date:5/16/2008)...g Campaign to Emphasize the Importance of Oral and...ire/ -- National dental insurer United,Concordia D...boration,between Oral Health America and the Briti...nce of oral health to overall health. Beginning Ma... States for the first time,making it the largest ...
(Date:5/16/2008)...s chronic disease sufferers gain benefit from calc...(HealthDay News) -- Taking activated vitamin D may... severe chronic kidney disease by about one quarte...tudy of more than 1,400 patients, those being trea...amin D, had their overall risk of death lowered by...
Breaking Medicine News(10 mins):Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 2Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 3Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 4Health News:Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease 5Health News:United Concordia Dental Celebrates National Smile Month 2Health News:Vitamin D Use Linked to Lower Mortality in Kidney Patients 2(Date:5/16/2008)...gy Enables First-Ever PEGylation of a Small Molecu... Activity, SAN CARLOS, Calif., May 16 /PRNewswire...) announced initial results today from a Phase 1,s...shows significant,anti-tumor activity in patients ...strates that Nektar,s small molecule PEGylation te...
(Date:5/15/2008)...onfirm Efficacy for Population Most Affected by Di...16 /-,Bayer HealthCare Phar...Nasdaq: ONXX ) today announced that Nexavar(R) (s...urvival by 47.3 percent (HR=0.68;,p-value=0.014) i...d,hepatocellular carcinoma (HCC), or primary liver...
(Date:5/15/2008)...cacy Clinical Data from Prostate, Colorectal and O... Company to Hold Investor Event on Sun., June 1 wi...., May 15 /- Poniard,Pharma...cal company focused,on oncology, today announced t...cal trials of picoplatin, in various tumor types a...
(Date:5/15/2008)...uctions demonstrated in Blacks, Hispanics/Latinos,...ndividuals, PARSIPPANY, N.J., May 15 /PRNewswire/...a presented at the American Society of,Hypertensio...008) in New,Orleans demonstrated that the powerful...tan medoxomil) safely and effectively helped,patie...
Breaking Medicine Technology:Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 2Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 3Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 4Significant Anti-Tumor Activity of NKTR-102 in Patients With Refractory Solid Tumors; Interim Data Published in ASCO 2008 Proceedings 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 2Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 3Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 4Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Finola Hughes Announces Her Best Accessory at Fashion Week 10829 1Finola Hughes Announces Her Best Accessory at Fashion Week 10829 2Finola Hughes Announces Her Best Accessory at Fashion Week 10829 3Natural Nutrition Operating Subsidiary Reports Record 29 25 Increase in Revenues for 2007 of 2417 460 000 10827 1Natural Nutrition Operating Subsidiary Reports Record 29 25 Increase in Revenues for 2007 of 2417 460 000 10827 2Diagnostic Centers of America Retains NewsMark Public Relations to Showcase Its Rise as Only Medical Facility in South Florida With Worlds Most Advanc 10823 1Diagnostic Centers of America Retains NewsMark Public Relations to Showcase Its Rise as Only Medical Facility in South Florida With Worlds Most Advanc 10823 2Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland 2951 1Synosia Therapeutics Appoints Chief Financial Officer to New Company Headquarters in Switzerland 2951 2...Impact of Pain on Sleep Interference, INDIANAPOLIS... a,pooled analysis of three studies suggest that i...ge, or diabetic peripheral neuropathy,who are tre...in,both average daily pain and night pain severity...rference than in those patients,taking sugar pill....
...SX Venture Exchange, EDMONTON, May 02, 2007 /PRNew...or the "Company") Quest is pleased to provide an,u... the treatment,of prostate cancer. , Prostate canc...American men with approximately 230,000 new cases ...dalities for localized prostate,cancer are associa...
Other Medicine Technology:Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 2Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 3Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 4Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 5Data Suggest Cymbalta Reduced Severity of Night Pain in Patients,with Diabetic Nerve Pain 6Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3...S solution tricompartmental total knee prosthesis ...roplasty. State-of-the-art design and manufacturin...optimum biomechanical function as well as a favora...ene tibial insert to keep wear to a minimum. The i...
...knee system was designed for patients with difficu...ons needed custom designs to repair difficult anat... Factor' which reduces the chance of dislocation i...tation has been streamlined and updated so that th...
The design and concept of the Alpina knee allows the choice of implanting a PCL retaining or a posterior stabilized prosthesis intraoperatively.
...S Solution tricompartmental total knee prosthesis ...roplasty. State-of-the-art design and manufacturin...optimum biomechanical function as well as a favora...ene tibial insert to keep wear to a minimum. The i...
Medicine Products: